{
    "clinical_study": {
        "@rank": "6355", 
        "arm_group": [
            {
                "arm_group_label": "group-A and group-B", 
                "description": "Group-A (0.5% hyperbaric bupivacaine 0.4 mg/kg for 5-15 kg or 0.3mg/kg for >15kg) and Group-B (0.5% hyperbaric bupivacaine 0.4 mg/kg for 5-15 kg or 0.3mg/kg for >15 with 1 mcg/kg preservative free clonidine)."
            }, 
            {
                "arm_group_label": "group-A and group--B", 
                "description": "Group-A (0.5% hyperbaric bupivacaine 0.4 mg/kg for 5-15 kg or 0.3mg/kg for >15kg) and Group-B (0.5% hyperbaric bupivacaine 0.4 mg/kg for 5-15 kg or 0.3mg/kg for >15 with 1 mcg/kg preservative free clonidine)."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators can summarize intrathecal clonidine can potentiate bupivacaine thereby\n      bringing about better quality and longer duration of analgesia, better sedation and better\n      postoperative outcomes with minimal side effects."
        }, 
        "brief_title": "Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": "Pediatric Spinal Anesthesia", 
        "detailed_description": {
            "textblock": "In our Randomized controlled, double blind study involving 30 subjects in two groups; the\n      investigators compared the safety, efficacy and quality of using intrathecal hyperbaric\n      bupivacaine 0.5% and hyperbaric bupivacaine 0.5% with clonidine 1\u00b5g/kg in paediatric\n      patients undergoing surgeries below T8 dermatome.\n\n      American Society of Anesthesiologists (ASA) Grade I patients aged between 3-10 years were\n      scheduled for the surgeries below T8 dermatome up to two hrs duration. The patients were\n      randomly allocated in - Group A-who received 0.5%of hyperbaric Bupivacaine 0.4mg/kg for 5\n      to15 kg or 0.3 mg/kg for more than 15 kg intrathecally.\n\n      Group B-who received 0.5%of hyperbaric Bupivacaine 0.4mg/kg for 5 to15 kg or 0.3 mg/kg for\n      more than 15 kg and 1\u00b5g/kg preservative free clonidine intrathecally.\n\n      The patients studied across the group did not vary much with respect to age, weight and sex\n      distribution."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. ASA grade-1 physical status.\n\n          2. weight 5-35kg\n\n          3. age-3 to 10 yrs\n\n        Exclusion Criteria:\n\n          1. patients with known sensitivity to drugs to be used.\n\n          2. gross spinal deformity\n\n          3. patients in whom regional anesthesia is contraindicated.\n\n          4. patients with peripheral neuropathy.\n\n          5. patient with hemodynamic instability."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "10 Years", 
            "minimum_age": "3 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "prospective,randomized,double blind study cariied in 60 ASA grade 1 pediatric patients\n        undergoing surgeries below T8 dermatome upto two hours duration."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01661803", 
            "org_study_id": "acpm anesthesia.dhule."
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Clonidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "bupivacaine", 
            "clonidine", 
            "pediatric spinal", 
            "efficacy", 
            "duration", 
            "quality", 
            "side effects", 
            "intrathecal bupivacaine alone", 
            "bupivacaine plus clonidine"
        ], 
        "lastchanged_date": "August 9, 2012", 
        "number_of_groups": "2", 
        "official_title": "Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01661803"
        }, 
        "responsible_party": {
            "investigator_affiliation": "ACPM Medical College", 
            "investigator_full_name": "DR.NAGESH JAMBURE", 
            "investigator_title": "resident,anesthesia department,a.c.p.m.medical college,dhule,maharashtra,india", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "ACPM Medical College", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ACPM Medical College", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2009", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}